Theerasak Rojanarata

Dr. Theerasak Rojanarata


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Analytica Chimica Acta
Verified
Journal Article
Closed access
VPVitsarut Primpray
Vitsarut Primpray
OCOrawon Chailapakul
Orawon Chailapakul
MTManabu Tokeshi
Manabu Tokeshi
TRTheerasak Rojanarata
Theerasak Rojanarata
WLWanida Laiwattanapaisal
Wanida Laiwattanapaisal

1 March 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
NPNoppharat Phadungcharoen
Noppharat Phadungcharoen
PPPrasopchai Patrojanasophon
Prasopchai Patrojanasophon
POPraneet Opanasopit
Praneet Opanasopit
TNTanasait Ngawhirunpat
Tanasait Ngawhirunpat
ACAkhayachatra Chinsriwongkul
Akhayachatra Chinsriwongkul
TRTheerasak Rojanarata
Theerasak Rojanarata

1 October 2020 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
PPPrasopchai Patrojanasophon
Prasopchai Patrojanasophon
STSiripran Tidjarat
Siripran Tidjarat
POPraneet Opanasopit
Praneet Opanasopit
TNTanasait Ngawhirunpat
Tanasait Ngawhirunpat
TRTheerasak Rojanarata
Theerasak Rojanarata
Cellulose acetate nanofibers with different degrees of alignment (randomly aligned (RA), partially aligned (PA), and highly aligned (HA)) were produced using an electrospinning technique. The different degrees of alignment were obtained by adjusting the rotation speed of the collector. Alpha-arbutin (3% w/w) employed as a model water-soluble compound was incorporated into the nanofibers during the fabrication process. The drug release characteristics were investigated using the nanofiber mats with the same size and weight. The prepared nanofibers with different degrees of alignment showed similar physical characteristics, including the fiber diameter, drug loading efficiency and capacity, and molecular form of the drug in the fibers. Interestingly, alpha-arbutin was released from HA nanofibers at a significantly faster rate than the PA and RA nanofibers. Eighty percent of the drug was released into the medium in 1.7, 4.2, and 9.4 min for HA, PA, and RA nanofibers, respectively. The orientation of nanofibers played a crucial role in governing the drug release, probably by creating network meshes with different degrees of entanglement, affecting the diffusion of drug to the external medium. Consequently, this approach can be used as a simple means of achieving immediate-release or fast-acting characteristics of cellulose-based formulations containing a water-soluble drug.

1 October 2021 in Talanta
Verified
Journal Article
Closed access
KRKanong Ruttanakorn
Kanong Ruttanakorn
NPNoppharat Phadungcharoen
Noppharat Phadungcharoen
WLWanida Laiwattanapaisal
Wanida Laiwattanapaisal
ACAkhayachatra Chinsriwongkul
Akhayachatra Chinsriwongkul
TRTheerasak Rojanarata
Theerasak Rojanarata

1 November 2020 in Talanta
Verified
Journal Article
Closed access
NPNoppharat Phadungcharoen
Noppharat Phadungcharoen
NPNatthapat Pengwanput
Natthapat Pengwanput
ANApisara Nakapan
Apisara Nakapan
USUrassaya Sutitaphan
Urassaya Sutitaphan
PTPaweenut Thanomklom
Paweenut Thanomklom
TRTheerasak Rojanarata
Theerasak Rojanarata

6 June 2024 in Pharmacia
Verified
Journal Article
Open access
PDF file
PSPhuvamin Suriyaamporn
Phuvamin Suriyaamporn
BPBoonnada Pamornpathomkul
Boonnada Pamornpathomkul
PWPawaris Wongprayoon
Pawaris Wongprayoon
TRTheerasak Rojanarata
Theerasak Rojanarata
TNTanasait Ngawhirunpat
Tanasait Ngawhirunpat
POPraneet Opanasopit
Praneet Opanasopit
The application of Artificial Intelligence (AI) has the potential to revolutionize the formulation development of nanomedicine. This study investigated the physicochemical characteristics of progesterone-loaded solid-lipid nanoparticles (PG-SLNs) produced through an emulsification–ultrasonication process, with a focus on demonstrating the efficacy of this controlled preparation method via the Design of Experiments (DoE) and Artificial Neural Networks (ANN). Critical quality factors, including stearic acid, medium chain triglycerides (MCT), Pluronic F-127, and the amount of propylene glycol (PG), were explored using DoE to streamline experimental setups. The concentration of stearic acid was identified as a crucial factor influencing PG-SLN physicochemical properties, impacting particle size (PS), polydispersity index (PDI), zeta potential (ZP), and %drug loading (%DL). Optimal conditions for PS, PDI, ZP, and %DL were identified. DoE revealed acceptable values across multiple runs, and the ANN model demonstrates high prediction accuracy, surpassing Response Surface Methodology (RSM). The selected PG-SLN formulation was tested for transdermal drug delivery, showing improved permeation compared to PG suspension. Loading with limonene further enhances transdermal drug delivery, attributed to limonene’s role as a penetration enhancer. Moreover, the selected PG-SLN formulation was found to be safe and non-toxic to neuronal cells. The combination of DoE and ANN was proposed to enhance predictive ability. This research highlights the potential of PG-SLNs in transdermal drug delivery, emphasizing the role of limonene as a safe and effective enhancer. The study contributes to the growing interest in applying AI tools in pharmaceutical and biomedical fields for improved predictive modeling.